182 related articles for article (PubMed ID: 34351467)
1. Carcinosarcomas of the larynx: systematic review of the literature of a rare nosologic entity.
Colizza A; Gilardi A; Greco A; Cialente F; Zoccali F; Ralli M; Minni A; de Vincentiis M
Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1167-1173. PubMed ID: 34351467
[TBL] [Abstract][Full Text] [Related]
2. Multimodality Treatment Options and Outcomes of Laryngeal Carcinosarcoma: A Clinical Analysis of a Rare Tumor from a Single Hospital.
Zhang Y; Huang Z; Gross N; Fang J; Chen X; Chen X; Hou L; Li P; Li G; Zhong Q
Biomed Res Int; 2019; 2019():1754675. PubMed ID: 31317023
[TBL] [Abstract][Full Text] [Related]
3. Carcinosarcoma of the larynx consisting of squamous cell carcinoma and inflammatory myofibroblastic tumor components.
Suzuki S; Hanata K; Toyoma S; Nanjo H; Saito H; Iikawa N; Ishikawa K
Auris Nasus Larynx; 2016 Aug; 43(4):460-3. PubMed ID: 26689319
[TBL] [Abstract][Full Text] [Related]
4. True carcinosarcoma of the larynx.
Zhang M; Zhao LM; Li XM; Zhou L; Lin L; Wang SY
J Laryngol Otol; 2013 Jan; 127(1):100-3. PubMed ID: 23217441
[TBL] [Abstract][Full Text] [Related]
5. The management of laryngeal cancer.
Bryce DP
J Otolaryngol; 1979 Apr; 8(2):105-26. PubMed ID: 430578
[TBL] [Abstract][Full Text] [Related]
6. [Management of T3 supraglottic carcinoma: a retrospective study].
Liu WS; Li ZJ; Zhang GF; Xu ZG; Tang PZ; Tu GY
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):613-617. PubMed ID: 28835085
[No Abstract] [Full Text] [Related]
7. Clinical staging for primary malignancies of the supraglottic larynx.
Zamora RL; Harvey JE; Sessions DG; Spitznagel EL
Laryngoscope; 1993 Jan; 103(1 Pt 1):69-77. PubMed ID: 8421423
[TBL] [Abstract][Full Text] [Related]
8. Outcome after supracricoid laryngectomies in the material of ENT Department, Poznan University of Medical Sciences.
Szyfter W; Leszczyńska M; Wierzbicka M
Eur Arch Otorhinolaryngol; 2011 Jun; 268(6):879-83. PubMed ID: 21305310
[TBL] [Abstract][Full Text] [Related]
9. Supracricoid partial laryngectomy as a primary treatment for carcinosarcoma of the larynx.
Luna-Ortiz K; Mosqueda-Taylor A
Ear Nose Throat J; 2006 May; 85(5):337-41. PubMed ID: 16771029
[TBL] [Abstract][Full Text] [Related]
10. pT3 N0 Laryngeal Squamous Cell Carcinoma: Oncologic Outcomes and Prognostic Factors of Surgically Treated Patients.
Mattioli F; Fermi M; Molinari G; Capriotti V; Melegari G; Bertolini F; D'Angelo E; Tirelli G; Presutti L
Laryngoscope; 2021 Oct; 131(10):2262-2268. PubMed ID: 33755212
[TBL] [Abstract][Full Text] [Related]
11. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
12. Laryngeal cancer: United Kingdom National Multidisciplinary guidelines.
Jones TM; De M; Foran B; Harrington K; Mortimore S
J Laryngol Otol; 2016 May; 130(S2):S75-S82. PubMed ID: 27841116
[TBL] [Abstract][Full Text] [Related]
13. Partial laryngectomy after irradiation failure.
Yiotakis J; Stavroulaki P; Nikolopoulos T; Manolopoulos L; Kandiloros D; Ferekidis E; Adamopoulos G
Otolaryngol Head Neck Surg; 2003 Feb; 128(2):200-9. PubMed ID: 12601315
[TBL] [Abstract][Full Text] [Related]
14. [Horizontal laryngectomy in treatment of laryngeal cancer--oncologic and function results].
Jaworowska E
Ann Acad Med Stetin; 1998; 44():175-95. PubMed ID: 9857538
[TBL] [Abstract][Full Text] [Related]
15. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.
Vilaseca I; Blanch JL; Berenguer J; Grau JJ; Verger E; Muxí Á; Bernal-Sprekelsen M
Head Neck; 2016 Jul; 38(7):1050-7. PubMed ID: 26872432
[TBL] [Abstract][Full Text] [Related]
16. [Topographical and clinico-oncologic analysis of locoregional recurrence after transoral laser surgery for laryngeal cancer].
Eckel HE
Laryngorhinootologie; 1993 Aug; 72(8):406-11. PubMed ID: 8397594
[TBL] [Abstract][Full Text] [Related]
17. Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx.
Kligerman J; Olivatto LO; Lima RA; Freitas EQ; Soares JR; Dias FL; Melo LE; Sá GM; Duccini E
Am J Surg; 1995 Nov; 170(5):436-9. PubMed ID: 7485727
[TBL] [Abstract][Full Text] [Related]
18. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy.
Spriano G; Antognoni P; Sanguineti G; Sormani M; Richetti A; Ameli F; Piantanida R; Luraghi R; Magli A; Corvo R; Tordiglione M; Vitale V
Am J Otolaryngol; 2000; 21(1):14-21. PubMed ID: 10668672
[TBL] [Abstract][Full Text] [Related]
20. Salvage Surgery after Radiation Failure in T1/T2 Larynx Cancer: Outcomes following Total versus Conservation Surgery.
Cheraghlou S; Kuo P; Mehra S; Yarbrough WG; Judson BL
Otolaryngol Head Neck Surg; 2018 Mar; 158(3):497-504. PubMed ID: 29292665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
